🇺🇸 FDA
Pipeline program

FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TOCILIZUMAB, YTB323

CYTB323G12101

Phase 2 small_molecule active

Quick answer

FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TOCILIZUMAB, YTB323 for Systemic Lupus Erythematosus., Lupus Nephritis is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Systemic Lupus Erythematosus., Lupus Nephritis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials